Community/Retail

The FDA has accepted the new drug application (NDA) for EZR-201, an investigational product from Ezra Innovations for the treatment of hypertension and heart failure.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Torbjörn Tomson, MD, PhD - professor in neurology, Karolinska Institutet - discusses how health care providers can work with patients to prevent sudden unexpected death in epilepsy (SUDEP).

A new CDC report assesses factors that influence pregnant women’s adherence to vaccination coverage recommendations.

Epilepsy medications can cause folate deficiency-related birth defects but what about other birth defects?

The FDA announced the approval of Trulance (plecanatide), Synergy’s once-daily oral treatment for chronic idiopathic constipation (CIC) in adult patients.

The FDA has approved Allergan’s newest topical treatment for persistent facial erythema.

The FDA has approved the first generic version of Xyrem (sodium oxybate) oral solution for patients with narcolepsy under strict safety requirements.

A man was recently sentenced to 57 months of imprisonment for his involvement in a drug trafficking organizations’ conspiracy scheme.

The Walgreens Flu Index is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranking of those experiencing the highest incidences of influenza across the country.

For the second consecutive year, the Meijer LPGA Classic for Simply Give was recognized as the “Best Tournament” on the LPGA Tour.

Developed by leading cannabinoid research and development company Axim Biotech, the cannabidiol (CBD) gum is designed to alleviate symptoms of IBS.

Here's one for one for Kübler-Ross.

Live the life and career you want with these tips.

Aspirin can save lives from certain types of cancer related deaths, and prevent certain types of cancers from occuring

We pharmacists have found ourselves stuck in the crossfire of a national opiate epidemic.

The FDA has approved Teva’s Vantrela ER (hydrocodone bitartrate) extended-release tablets.

Amidst recent efforts to dismantle the Affordable Care Act, a newly-released report has suggested that repealing several provisions of the health reform law could potentially raise premiums and leave millions of Americans without health insurance coverage.

When you think about recent “disruptors” to the consumer marketplace, you can look around your own neighborhood to see the effects of Uber, Airbnb, and even the craft beer movement.

Requirements will vary based on the nature of the proposed interchangeable product, and may include an evaluation of data and information generated to support a demonstration of a biological product’s biosimilarity.

This article highlights 5 published case reports that document medications treating conditions they aren’t FDA-approved for.

Down syndrome results in a massive genetic imbalance in those who have the disorder.

For the fourth consecutive year, the National Community Pharmacists Association (NCPA) has asked its members to rank their most important legislative and regulatory priorities.

The drug failed to demonstrate a statistically significant difference from placebo in the change from baseline of the investigator rating of the Conners’ Adult ADHD Rating Scales (CAARS).

The FDA is allowing the sale of EU-approved Panretin gel (alitretinoin 0.1%) tubes in the United States due to a shortage of the US-approved gel.

Five years after the deadly outbreak, the owner and former head pharmacist of the NECC faces charges for racketeering, mail fraud, and murder.